Skip to main content

Month: July 2020

RedHill Biopharma Publishes Positive IBS-D Phase 2 Study Data in The American Journal of Gastroenterology

Publication of the Phase 2 U.S. study data show that RHB-102 (Bekinda®) 12mg delivers a clinically meaningful improvement in overall stool consistency response versus placebo in patients with diarrhea-predominant irritable bowel syndrome (IBS-D), meeting the study’s primary endpoint—In addition, the publication highlights that elevated baseline C-reactive protein (CRP) may be used to identify treatment responders in this complex disease, which lacks reliable predictive markers— The 126-patient study was conducted in 16 sites across the U.S.—RHB-102, a novel, proprietary, once-daily bimodal release formulation of ondansetron that allows for both immediate relief and 24-hour maintenance of effect, is also in Phase 3 development for acute gastroenteritis and gastritisTEL AVIV, Israel and RALEIGH, N.C., July 28, 2020 (GLOBE...

Continue reading

Edge Data Solutions, Inc. Adds Austin Bosarge to the Board of Directors

ATLANTA, July 28, 2020 (GLOBE NEWSWIRE) — Edge Data Solutions, Inc. (OTC:EDGS) a leading-edge datacenter and cloud infrastructure company, is pleased to announce the addition of Austin Bosarge to the board of directors. Austin has worked as general counsel for the company for the last two years offering key legal and business advice in the process.“Austin has been advising companies as corporate counsel for 20+ years and I know that experience will help our company grow,” said Delray Wannemacher, CEO and Chairman of EDSI. “Austin has been working with us very closely and I am confident in his ability to help us going forward at this critical point of growth.”Austin started Turning Point Law in 1997 and has served as a key legal and business advisor to private emerging companies in business operations, IP protection, software development...

Continue reading

Tribune Publishing Adopts Limited Duration Stockholder Rights Agreement

CHICAGO, July 28, 2020 (GLOBE NEWSWIRE) — Tribune Publishing Company (NASDAQ: TPCO) announced today that its Board of Directors has approved the adoption of a limited duration stockholder rights agreement (the “Rights Agreement”) and declared a dividend distribution of one right (“Right”) for each outstanding share of common stock outstanding as of the record date. The record date for such dividend distribution is August 7, 2020. The Rights expire, without any further action being required to be taken by the Tribune Publishing Board of Directors, on July 27, 2021.The adoption of the Rights Agreement is intended to enable all Tribune Publishing stockholders to realize the full potential value of their investment in the company and to protect the interests of the Company and its stockholders by reducing the likelihood that any person...

Continue reading

PAVmed to Hold Business Update Conference Call on August 18, 2020

NEW YORK, July 28, 2020 (GLOBE NEWSWIRE) — PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical device company, today announced that the Company will host a business update conference call on Tuesday, August 18, 2020 at 4:30 p.m. Eastern time. During the call, Lishan Aklog, M.D., Chairman and Chief Executive Officer of the Company, will provide a business update including an overview of the Company’s near-term milestones and growth strategy. In addition, Dennis McGrath, the Company’s President and Chief Financial Officer, will discuss second quarter 2020 financial results.To access the conference call, U.S.-based listeners should dial (877) 407-3982 and international listeners should dial (201) 493-6780. All listeners should provide the operator with the...

Continue reading

QDX™ HealthID Expands its COVID-19 Ecosystem with MIG USA Antibody Test Kits and other Contagion Mitigation Products

The QDX™ HealthID ecosystem adds MIG USA serology tests.Once FDA EUA approval is granted, MIG USA to offer QDX™ HealthIDto persons taking its tests, including its own employeesSan Marcos, TX and High Point, NC, July 28, 2020 (GLOBE NEWSWIRE) — QDX HealthID Incorporated, a wholly-owned subsidiary of Quantum Materials Corp (OTC Bulletin Board: QTMM) – today announced that in conjunction with its parent it has signed an agreement with MIG USA, for the inclusion of MIG USA and affiliates’ test kits in the QDX™ HealthID ecosystem. Additionally, the agreement allows for MIG USA to offer QDX™ HealthID to users of its test kits.QDX™ HealthID, currently in beta release, is a SaaS-based platform that allows companies and individuals to see and select a particular COVID-19 test kit, authenticate and record the test results in a secure way,...

Continue reading

Industry’s First MCU-based Implementation of Glow Neural Network Compiler for Machine Learning at the Edge

Demonstrating the wide-ranging benefits of Glow NN compiler for vision- and voice-based machine learning applications – NXP is the first semiconductor vendor to deliver a 2-3x performance jump for MCUs over the standard version of GlowOriginally developed by Facebook, the open source Glow compiler is now available in NXP’s eIQ™ Machine Learning Software Development Environment delivering high performance inferencing for NXP’s i.MX RT series of crossover MCUsNXP’s implementation of Glow targets Arm® Cortex®-M cores and the Cadence® Tensilica® HiFi 4 DSP, with platform-specific optimizations for its i.MX RT series of crossover MCUsEINDHOVEN, The Netherlands, July 28, 2020 (GLOBE NEWSWIRE) — NXP Semiconductors N.V. (NASDAQ: NXPI) today released its eIQ Machine Learning (ML) software support for Glow neural network (NN) compiler,...

Continue reading

NYMOX Provides Current Update on Key Company Developments

HASBROUCK HEIGHTS, N.J., July 28, 2020 (GLOBE NEWSWIRE) — Nymox Pharmaceutical Corporation (NASDAQ: NYMX) is pleased to report current updates on the Company’s most important ongoing developments. The Company reports further significant and important progress has been made with remaining items for the upcoming regulatory filings in 2020 for the Company’s first in class innovative prostate drug Fexapotide Triflutate (FT). The Company has moved swiftly ahead on its regulatory marketing applications by remote work with a strong team of expert collaborators, even with the occasional difficulties from the Covid situation leading to restricted or delayed access to certain required sources and to sites included in the Company’s studies.Nymox is also pleased to announce that it has recently formally filed with the regulatory...

Continue reading

Pershimex Intercepts 33.3 g/t of Gold over 6.6 Meters in the Crown Pillar of the Former Pershing-Manitou Mine

ROUYN-NORANDA, Quebec, July 28, 2020 (GLOBE NEWSWIRE) — Pershimex Resources Corporation (“Pershimex” or the “Company”) (TSX VENTURE: PRO) is pleased to announce the results of the drilling campaign carried out in the winter of 2020. On the 16 holes, 12 contained coarse visible gold and only 3 of them (PM-20-01, PM-20-08 and 09) did not contain significant gold value. The best mineralized intersections are located in the heart of the surface pillar.  Two holes (PM-20-04 and PM-20-16 A) having reverse azimuths (one opposite the other, see figure 1) have intercepted high grades of gold within 20 meters of the surface. Hole PM-20-04 intercepted 33.3 g/t Au over 6.6 meters while hole PM-20-16A intercepted 10.4 g/t Au over 3.3 meters. The results obtained confirm the presence of high grade gold mineralization in...

Continue reading

Pershimex intercepte 33,3 g/t d’or sur 6,6 mètres dans le pilier de surface de l’ancienne mine Pershing-Manitou

ROUYN-NORANDA, Québec, 28 juill. 2020 (GLOBE NEWSWIRE) — Corporation Ressources Pershimex (“Pershimex” ou  la “Société”) (TSX CROISSANCE: PRO) est heureuse d’annoncer les résultats de la campagne de forage réalisée à l’hiver 2020. Sur les 16 forages, 12 contenaient de l’or visible grossier et seulement 3 d’entre eux (PM-20-01, PM-20-08 et 09) ne contenaient pas de valeur aurifère significative. Les meilleures intersections minéralisées sont situées en plein cœur du pilier de surface, deux sondages (PM-20-04 et PM-20-16 A) ayant des azimuts inverses (l’un à l’opposé de l’autre, voir figure 1) ont interceptés des hautes teneurs en or et ce à moins de 20 mètres de la surface. Le sondage PM-20-04 a recoupé 33,3 g/t d’or sur 6,6 mètres alors que le sondage PM-20-16A a recoupé 10,4 g/t d’or sur 3,3 mètres. Les...

Continue reading

Update to NoHo Partners’ reporting schedules for turnover in July and August 2020

NoHo Partners PlcSTOCK EXCHANGE RELEASE 28 July 2020 at 16:30Update to NoHo Partners’ reporting schedules for turnover in July and August 2020NoHo Partners will report the company’s development of turnover in July 2020 in connection with the release of the January–June 2020 half-year report on 11 August 2020. The company announced previously that it will report its development of turnover in July during the first week of August.The development of turnover in August 2020 will be reported by the Group on Tuesday 8 September 2020.More information available from:Aku Vikström, CEO, NoHo Partners Plc, tel. +358 44 011 1989Jarno Suominen, Deputy CEO, NoHo Partners Plc, tel. +358 40 721 5655                                                                                                            Distribution:Nasdaq HelsinkiMajor mediawww.noho.fiNoHo...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.